188 related articles for article (PubMed ID: 33346835)
1. Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017.
Patil N; Kelly ME; Yeboa DN; Buerki RA; Cioffi G; Balaji S; Ostrom QT; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2021 Jun; 23(6):990-998. PubMed ID: 33346835
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
[TBL] [Abstract][Full Text] [Related]
3. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
5. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E
J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
7. Brain and other central nervous system tumor statistics, 2021.
Miller KD; Ostrom QT; Kruchko C; Patil N; Tihan T; Cioffi G; Fuchs HE; Waite KA; Jemal A; Siegel RL; Barnholtz-Sloan JS
CA Cancer J Clin; 2021 Sep; 71(5):381-406. PubMed ID: 34427324
[TBL] [Abstract][Full Text] [Related]
8. CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.
Price M; Neff C; Nagarajan N; Kruchko C; Waite KA; Cioffi G; Cordeiro BB; Willmarth N; Penas-Prado M; Gilbert MR; Armstrong TS; Barnholtz-Sloan JS; Ostrom QT
Neuro Oncol; 2024 May; 26(Supplement_3):iii1-iii53. PubMed ID: 38709657
[TBL] [Abstract][Full Text] [Related]
9. Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study.
Hsu S; Quattrone M; Ostrom Q; Ryken TC; Sloan AE; Barnholtz-Sloan JS
J Neurosurg Spine; 2011 Jun; 14(6):742-7. PubMed ID: 21395394
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
11. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Ostrom QT; Patil N; Cioffi G; Waite K; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2020 Oct; 22(12 Suppl 2):iv1-iv96. PubMed ID: 33123732
[TBL] [Abstract][Full Text] [Related]
12. Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT.
Price M; Neff C; Kruchko C; Barnholtz-Sloan JS; Cordeiro BB; Penas-Prado M; Ozer BH; Cimino PJ; Gilbert MR; Armstrong TS; Ostrom QT
J Neurooncol; 2023 Nov; 165(2):279-290. PubMed ID: 37980692
[TBL] [Abstract][Full Text] [Related]
13. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
14. Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas.
Wang GM; Cioffi G; Patil N; Waite KA; Lanese R; Ostrom QT; Kruchko C; Berens ME; Connor JR; Lathia JD; Rubin JB; Barnholtz-Sloan JS
Neuro Oncol; 2022 Feb; 24(2):302-310. PubMed ID: 34387331
[TBL] [Abstract][Full Text] [Related]
15. Racial/Ethnic Disparities and Survival in Pediatrics with Gliomas Based on the Surveillance, Epidemiology, and End Results Database in the United States.
Jiang W; Rixiati Y; Kuerban Z; Simayi A; Huang C; Jiao B
World Neurosurg; 2020 Sep; 141():e524-e529. PubMed ID: 32492539
[TBL] [Abstract][Full Text] [Related]
16. Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.
Buczkowicz P; Bartels U; Bouffet E; Becher O; Hawkins C
Acta Neuropathol; 2014 Oct; 128(4):573-81. PubMed ID: 25047029
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
Hipp SJ; Goldman S; Kaushal A; Krauze A; Citrin D; Glod J; Walker K; Shih JH; Sethumadhavan H; O'Neill K; Garvin JH; Glade-Bender J; Karajannis MA; Atlas MP; Odabas A; Rodgers LT; Peer CJ; Savage J; Camphausen KA; Packer RJ; Figg WD; Warren KE
J Neurooncol; 2020 Sep; 149(3):437-445. PubMed ID: 33040274
[TBL] [Abstract][Full Text] [Related]
19. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.
Truitt G; Gittleman H; Leece R; Ostrom QT; Kruchko C; Armstrong TS; Gilbert MR; Barnholtz-Sloan JS
J Neurooncol; 2019 Aug; 144(1):53-63. PubMed ID: 31209773
[TBL] [Abstract][Full Text] [Related]
20. Pediatric neuro-oncology survival disparities in California.
Cooney T; Fisher PG; Tao L; Clarke CA; Partap S
J Neurooncol; 2018 May; 138(1):83-97. PubMed ID: 29417400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]